-
1
-
-
0015854966
-
Transection of the oesophagus for bleeding oesophageal varices
-
Pugh RNH, Murray-Lyon IM, Dawson J-L, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649.
-
(1973)
Br J Surg
, vol.60
, pp. 646-649
-
-
Pugh, R.N.H.1
Murray-Lyon, I.M.2
Dawson, J.-L.3
Pietroni, M.C.4
Williams, R.5
-
3
-
-
0021965806
-
Natural history of hepatocellular carcinoma and prognosis in relation to treatment
-
Okuda K, Ohtsuki T, Obata H, Tominatsu M, Okazaki N, Hasegawa H, Nakajima Y, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 1985;56:918-928.
-
(1985)
Cancer
, vol.56
, pp. 918-928
-
-
Okuda, K.1
Ohtsuki, T.2
Obata, H.3
Tominatsu, M.4
Okazaki, N.5
Hasegawa, H.6
Nakajima, Y.7
-
4
-
-
0031782818
-
A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients
-
The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. HEPATOLOGY 1998;28:751-755.
-
(1998)
Hepatology
, vol.28
, pp. 751-755
-
-
-
5
-
-
0032482661
-
Tamoxifen in the treatment of hepatocellular carcinoma: A randomised controlled trial
-
CLIP Group (Cancer of the Liver Italian Program). Tamoxifen in the treatment of hepatocellular carcinoma: a randomised controlled trial. Lancet 1998;352:17-20.
-
(1998)
Lancet
, vol.352
, pp. 17-20
-
-
-
6
-
-
33845382806
-
Non parametric estimation from incomplete observation
-
Kaplan EL, Meier E Non parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-481.
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, E.2
-
7
-
-
0013886333
-
Evaluation of survival data and two new rank order statistics arising in its consideration
-
Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
-
(1966)
Cancer Chemother Rep
, vol.50
, pp. 163-170
-
-
Mantel, N.1
-
8
-
-
0000336139
-
Regression models and life tables
-
Cox DR. Regression models and life tables. J R Stat Soc Series B 1972;34:187-220.
-
(1972)
J R Stat Soc Series B
, vol.34
, pp. 187-220
-
-
Cox, D.R.1
-
9
-
-
0011678771
-
Akaike's criteria
-
Armitage P, Colton T, eds. Chichester: Wiley
-
Stone M: Akaike's criteria. In: Armitage P, Colton T, eds. Encyclopedia of Biostatistics. Chichester: Wiley, 1998;123-124.
-
(1998)
Encyclopedia of Biostatistics
, pp. 123-124
-
-
Stone, M.1
-
10
-
-
0025286476
-
Measures of explained variation for survival data
-
Korn EL, Simon R. Measures of explained variation for survival data. Stat Med 1990;9:487-503.
-
(1990)
Stat Med
, vol.9
, pp. 487-503
-
-
Korn, E.L.1
Simon, R.2
-
11
-
-
0033066135
-
A new prognostic classification for predicting survival in patients with hepatocellular carcinoma
-
Chevret S, Trinchet JC, Mathieu D, Rached AA, Beaugrand M, Chastang C, for the Groupe d'Etude et de Traitment du Carcinome Hepatocellulaire. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. J Hepatol 1999;31:133-141.
-
(1999)
J Hepatol
, vol.31
, pp. 133-141
-
-
Chevret, S.1
Trinchet, J.C.2
Mathieu, D.3
Rached, A.A.4
Beaugrand, M.5
Chastang, C.6
-
12
-
-
0032879468
-
Prognosis of hepatocellular carcinoma: The BCLC staging classification
-
Llovet JM, Brù C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19:329-337.
-
(1999)
Semin Liver Dis
, vol.19
, pp. 329-337
-
-
Llovet, J.M.1
Brù, C.2
Bruix, J.3
-
13
-
-
7344258851
-
Prognostic significance of pathological and biological factors in hepatocellular carcinoma
-
Ng IO. Prognostic significance of pathological and biological factors in hepatocellular carcinoma. J Gastroenterol Hepatol 1998;13:666-670.
-
(1998)
J Gastroenterol Hepatol
, vol.13
, pp. 666-670
-
-
Ng, I.O.1
-
14
-
-
0029160089
-
Serum concentration of intercellular adhesion molecule-1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis
-
Shimizu Y, Minemura M, Tsukishiro T, Kashii Y, Miyamoto M, Nishimori H, Higuchi K, et al. Serum concentration of intercellular adhesion molecule-1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis. HEPATOLOGY 1995;22:525-531.
-
(1995)
Hepatology
, vol.22
, pp. 525-531
-
-
Shimizu, Y.1
Minemura, M.2
Tsukishiro, T.3
Kashii, Y.4
Miyamoto, M.5
Nishimori, H.6
Higuchi, K.7
-
15
-
-
0032958169
-
Soluble interleukin-2 receptor levels in hepatocellular cancer: A more sensitive marker than alfa fetoprotein
-
Izzo F, Cremona F, Delrio P, Leonardi E, Castello G, Pignata S, Daniele B, et al. Soluble interleukin-2 receptor levels in hepatocellular cancer: a more sensitive marker than alfa fetoprotein. Ann Surg Oncol 1999;6:178-185.
-
(1999)
Ann Surg Oncol
, vol.6
, pp. 178-185
-
-
Izzo, F.1
Cremona, F.2
Delrio, P.3
Leonardi, E.4
Castello, G.5
Pignata, S.6
Daniele, B.7
-
16
-
-
0033532910
-
Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma
-
Tannapfel A, Wasner M, Krause K, Geissler F, Katalinic A, Hauss J, Mossner J, et al. Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma. J Natl Cancer Inst 1999;91:1154-1158.
-
(1999)
J Natl Cancer Inst
, vol.91
, pp. 1154-1158
-
-
Tannapfel, A.1
Wasner, M.2
Krause, K.3
Geissler, F.4
Katalinic, A.5
Hauss, J.6
Mossner, J.7
-
17
-
-
0030846249
-
Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma
-
Shiota G, Kishimoto Y, Suyama A, Okubo M, Katayama S, Harada K, Ishida M, et al. Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma. J Hepatol 1997;27:661-668.
-
(1997)
J Hepatol
, vol.27
, pp. 661-668
-
-
Shiota, G.1
Kishimoto, Y.2
Suyama, A.3
Okubo, M.4
Katayama, S.5
Harada, K.6
Ishida, M.7
-
18
-
-
0010460074
-
Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma
-
Saffroy R, Lelong JC, Azoulay D, Salvucci M, Reynes M, Bismuth H, Debuire B, et al. Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma. Br J Cancer 1999:79:604-610.
-
(1999)
Br J Cancer
, vol.79
, pp. 604-610
-
-
Saffroy, R.1
Lelong, J.C.2
Azoulay, D.3
Salvucci, M.4
Reynes, M.5
Bismuth, H.6
Debuire, B.7
|